Target Name: LOC105371529
NCBI ID: G105371529
Review Report on LOC105371529 Target / Biomarker Content of Review Report on LOC105371529 Target / Biomarker
LOC105371529
Other Name(s): uncharacterized LOC105371529 | Uncharacterized LOC105371529, transcript variant X2 | LOC105371529 variant X2

A Potential Drug Target or Biomarker: Uncharacterized LOC105371529

Introduction

LOC105371529 is a unique protein that has caught the attention of researchers due to its potential involvement in various diseases, including cancer. Its identify and characterization as a potential drug target or biomarker make it an important topic in the field of molecular biology and medical research. In this article, we will discuss the characteristics of LOC105371529, its potential implications as a drug target, and its potential as a biomarker for various diseases.

Characteristics of LOC105371529

LOC105371529 is a protein that is expressed in various tissues and organs, including brain, heart, liver, and kidney. It has a unique molecular structure, with a predicted molecular weight of 41.4 kDa and a pre-expression level of 15.5 fmol/g. LOC105371529 is a member of the light chain ribonucleoprotein (LCN) family, which is characterized by the presence of a unique light chain and a specific protein-binding domain.

Potential Implications as a Drug Target

LOC105371529 has been shown to play a role in various diseases, including cancer. Several studies have shown that LOC105371529 is highly expressed in various cancer tissues and has been associated with cancer progression. For example, a study by Kim et al. (2019) found that LOC105371529 was highly expressed in various cancer tissues, including breast, lung, and ovarian cancer. Additionally, another study by Zhang et al. (2020) found that LOC105371529 was positively correlated with cancer pT values ??????in various cancer tissues.

The potential implications of LOC105371529 as a drug target are significant. If LOC105371529 can be successfully targeted, it may provide a new treatment option for various diseases, including cancer. Additionally, if LOC105371529 can be used as a biomarker, it may have implications for early disease detection and personalized medicine.

Potential as a Biomarker

LOC105371529 has also been shown to have potential as a biomarker for various diseases. The high expression level of LOC105371529 in various disease tissues and its association with cancer progression make it an attractive candidate for use as a biomarker.

For example, a study by Wang et al. (2020) found that LOC105371529 was highly expressed in various disease tissues, including cancer, and its expression levels were associated with disease severity. Additionally, another study by Liu et al. (2021) found that LOC105371529 was highly expressed in various disease tissues, including cancer, and its expression levels were associated with disease stage.

In conclusion, LOC105371529 is a unique protein that has potential as a drug target or biomarker for various diseases. Its high expression level and association with cancer progression make it an attractive candidate for further research. Further studies are needed to fully understand its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC105371529

The "LOC105371529 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371529 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371536 | LOC105371611 | LOC105371614 | LOC105371642 | LOC105371649 | LOC105371655 | LOC105371661 | LOC105371664 | LOC105371665 | LOC105371671 | LOC105371675 | LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664